Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000412076 | SCV000486375 | likely pathogenic | Alkaptonuria | 2016-05-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000412076 | SCV000942825 | pathogenic | Alkaptonuria | 2023-12-26 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 53 of the HGD protein (p.Arg53Gln). This variant is present in population databases (rs200808744, gnomAD 0.01%). This missense change has been observed in individual(s) with alkaptonuria (PMID: 25681086, 25804398; Invitae). ClinVar contains an entry for this variant (Variation ID: 370939). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HGD protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV001726153 | SCV001962514 | likely pathogenic | not provided | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Department Of Human Genetics, |
RCV000412076 | SCV004098926 | pathogenic | Alkaptonuria | no assertion criteria provided | research | The variant was originally described in AKU patients in PMID:25804398 and PMID: 25681086. It has been submitted to the HGD gene mutation database (http://hgddatabase.cvtisr.sk/, DB-ID: AKU_00AKU_00152). |